Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732) |
---|
05/07/2002 | US6384216 Purification of alkenyl compounds |
05/02/2002 | WO2002042244A2 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds |
05/02/2002 | WO2002034760A2 Compounds and methods |
05/02/2002 | US20020052514 1-(phenylmethyl)sulfonyl-2-hydroxymethyl pyrrolidine for example; use treating neurological disorders including physically damaged nerves and neurodegenerative diseases; treating alopecia and promoting hair growth |
05/02/2002 | US20020052512 Diaminopropionic acid derivatives |
05/02/2002 | US20020052510 N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres |
05/02/2002 | US20020052361 Pharmaceutical compositions and method for the treatment of hypertension |
05/02/2002 | US20020052360 Hydroxyalkanoylaminolactams and related structures as inhibitors of a beta protein production |
05/02/2002 | US20020052359 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting B-amyloid peptide release and/or its synthesis by use of such compounds |
05/02/2002 | EP1201651A2 Process for producing e-caprolactam and apparatus for the process |
05/02/2002 | EP1201649A1 Glucocorticoid receptor modulators |
05/02/2002 | EP1200406A1 Cyclic amides and imides having selective antagonist activity at alpha-1d adrenergic receptor |
05/02/2002 | EP1200095A1 Medicament with a protective effect against oxidative-toxic substances, particularly against cardiotoxic substances |
05/02/2002 | EP1021189B1 Desferri-exochelin for the treatment of atherosclerosis and vascular injury by prevention of vascular smooth muscle cell proliferation |
05/02/2002 | CA2427473A1 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds |
05/01/2002 | CN1083832C Method for preparing lactam |
04/30/2002 | US6380184 For increased production of wool, milk, and meat by treating animals with therapeutically effective amount of compound |
04/30/2002 | CA2059787C Hydrazine derivative and pesticidal composition comprising said derivative as an effective ingredient |
04/25/2002 | US20020049194 A benzoazepin or benzodiazepin derivatives, shows excellent anti-vasopressin activity, vasopressin agonistic activity and oxytocin antagonistic activity, and are useful as antagonist |
04/25/2002 | US20020049193 Inhibitors of the enzyme activity associated with immunophilin proteins, particularly peptidyl-prolyl isomerase, or rotamase, enzyme activity. |
04/25/2002 | US20020048687 Efficient light emission and excellent heat resistance |
04/24/2002 | CN1346341A Process to separate linear alkyl 5-formylvalerate |
04/23/2002 | CA2223403C Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) n-¬(aminoiminomethyl)phenylalkyl|-azaheterocyclylamide compounds |
04/18/2002 | US20020045748 Pentenenitrile reacted with carbon monoxide and water or alcohol in the presence of a source of Group VIII metal and a bidentate phosphine, arsine and/or stibine ligand to form cyanovaleric acid or ester |
04/18/2002 | US20020045747 Treating Alzheimer's disease both prophylactically and therapeutically |
04/17/2002 | EP1196389A1 N-heterocyclic derivatives with neuronal activity |
04/17/2002 | CN1083005C Quarternary substituted bleach activators |
04/16/2002 | US6372939 Hydroformylating 3-pentenenitrile in presence of catalyst comprising group viii element to produce mixture of formylvaleronitriles, oxidizing to cyanovaleric acids, catalytically hydrogenating to 6-aminocaproic acid and isomers |
04/11/2002 | WO2002028830A1 Novel phenylalanine derivatives |
04/11/2002 | WO2001019797A3 HYDROXYALKANOYL AMINOLACTAMS AND RELATED STRUCTURES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
04/11/2002 | US20020042508 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same |
04/11/2002 | US20020042442 Ureas and carbamates of N-Heterocyclic carboxylic acids and carboxylic acid isosteres |
04/11/2002 | US20020042413 Central nervous system disorders; cognition activators |
04/11/2002 | US20020042357 Polypharmacophoric agents |
04/09/2002 | US6369238 Processes for the preparation of derivatives of 4a, 5, 9, 10, 11, 12-hexahydro-6H-benzofuro-[3a, 3, 2-ef][2]benzazepine |
04/09/2002 | US6369221 Anticonvulsants, antiischemic agents; brain and nervous system disorder treatment |
04/09/2002 | US6369110 Substituted guanidine derivatives and process for producing the same |
04/04/2002 | WO2002026856A1 Twisted polymers, uses thereof and processes for the preparation of statistical copolymers |
04/04/2002 | WO2002026750A2 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation |
04/04/2002 | WO2002026705A2 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and their preparation |
04/04/2002 | WO2001089451A3 Protease inhibitors |
04/04/2002 | US20020040137 Process for producing epsilon-caprolactam and apparatus for the process |
04/03/2002 | EP1192165A2 Substituted heterocycle fused gamma-carbolines |
04/02/2002 | US6365770 Production of alkyl 6-aminocaproate |
03/28/2002 | WO2002024653A1 Compounds and methods for modulation of estrogen receptors |
03/28/2002 | WO2002024649A1 Substituted amino-aza-cycloalkanes useful against malaria |
03/28/2002 | US20020038059 Purification of alkenyl compounds |
03/28/2002 | US20020038047 Process to separate linear alkyl 5-formylvalerate |
03/28/2002 | CA2423315A1 Substituted amino-aza-cycloalkanes useful against malaria |
03/28/2002 | CA2423106A1 Compounds and methods for modulation of estrogen receptors |
03/27/2002 | EP1189905A1 Substituted heterocycle fused gamma-carbolines |
03/27/2002 | EP1189904A1 Substituted heterocycle fused gamma-carbolines |
03/27/2002 | EP0782574B1 Bicyclic carboxamides as 5-ht1a receptors ligands |
03/27/2002 | CN1342161A Tricyclic inhibitors of poly(ADP-ribose) polymerases |
03/27/2002 | CN1081630C Method of purifying 'epsilon'-caprolactam |
03/27/2002 | CN1081625C 1-aryl-2-acylamino-ethane compounds and their use as meurokinin especially neurokinin 1 antagonists |
03/26/2002 | US6362371 β2- adrenergic receptor agonists |
03/26/2002 | US6362333 Method for simultaneously producing a cyclic lactam and a cyclic amine |
03/26/2002 | US6362332 Coproduction of a cyclic lactam and a cyclic amine |
03/21/2002 | WO2002022572A2 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission) |
03/21/2002 | CA2422055A1 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission) |
03/20/2002 | EP1187810A2 Heterocyclic analgesic compounds and their use |
03/20/2002 | EP1187592A2 Alpha v integrin receptor antagonists |
03/20/2002 | CN1341102A Dopamine D1 receptor agonist compounds |
03/19/2002 | US6359128 Melt processability; controlling heating; colorless |
03/19/2002 | US6358993 Pharmaceutically active nitrogen ring compounds and methods of use thereof |
03/19/2002 | US6358942 Microbiocides and bactericides for treating grampositive, bacteroides, clostridium, mycobacterium, staphylococcus and streptococcus infections |
03/19/2002 | CA2079548C Carbamate derivatives of 4-amino-3- isoxazolidinones, 3-amino-1- hydroxypyrrolidin-2-ones and 1-amino-1- cyclopropanecarboxylic acid analogs, a process for their preparation and their use as medicaments |
03/14/2002 | WO2002020526A2 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
03/14/2002 | WO2002020475A2 Inhibitors of serine protease activity of matriptase or mtsp1 |
03/14/2002 | WO2001070673A3 CYCLIC β-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-$g(a) |
03/14/2002 | US20020032187 Method for stimulating bone formation |
03/14/2002 | US20020030014 Treatment/purification of lactam media of reaction |
03/14/2002 | CA2422157A1 Inhibitors of serine protease activity of matriptase or mtsp1 |
03/14/2002 | CA2421506A1 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
03/13/2002 | EP1186604A1 Benzazepine derivatives, process for the preparation of the same and uses thereof |
03/13/2002 | CN1340040A Stabilised compositions of 0-and N-vinyl compounds and the use of ammonium salts as stabilisers |
03/13/2002 | CN1339966A Medicament for treating hypertension |
03/12/2002 | US6355842 Process for the oxidation of substrates containing methyl, methylene or methine groups |
03/12/2002 | US6355805 β3-adrenergic receptor agonists |
03/07/2002 | WO2002017924A1 Method of treatment |
03/07/2002 | WO2002017712A2 Disubstituted benzenes as insecticides |
03/07/2002 | US20020028932 Process for the preparation of an N-alkyl or N-aryl carbamoyl derivative |
03/07/2002 | US20020028835 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
03/07/2002 | US20020028821 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors |
03/07/2002 | US20020028803 Controlling cell apoptosis |
03/06/2002 | EP0729453B1 Process for manufacturing caprolactam |
03/05/2002 | US6353099 Substituted ureas as cell adhesion inhibitors |
03/05/2002 | US6352981 Treat disorders which respond to dopamine d.sub.3 ligands such as schistosomiasis, schizophrenia, depression, neuroses or psychoses |
03/05/2002 | US6352562 Natural rubber stable to this method of cleaning |
02/28/2002 | WO2002016339A1 Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
02/28/2002 | US20020025957 Anticoagulants, cardiovascular disorders |
02/28/2002 | US20020025955 Substituted lactams as inhibitors of A beta protein production |
02/27/2002 | EP1182183A1 Anthracene derivatives and organic electroluminescent devices made by using the same |
02/27/2002 | EP0734398B1 Compounds and methods |
02/27/2002 | CN1337953A New thryoid receptor ligands and process II |
02/26/2002 | US6350883 Method for preparing lactam |
02/26/2002 | CA2206776C N-sulfonylindoline derivatives carrying an amide functional group, their preparation and the pharmaceutical compositions in which they are present |
02/21/2002 | WO2002014513A1 Use of polypeptide |
02/21/2002 | US20020022637 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |